Xiaofeng Chen

2.1k total citations
87 papers, 1.2k citations indexed

About

Xiaofeng Chen is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Xiaofeng Chen has authored 87 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Pulmonary and Respiratory Medicine, 41 papers in Oncology and 28 papers in Surgery. Recurrent topics in Xiaofeng Chen's work include Gastric Cancer Management and Outcomes (25 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (14 papers) and Colorectal Cancer Treatments and Studies (10 papers). Xiaofeng Chen is often cited by papers focused on Gastric Cancer Management and Outcomes (25 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (14 papers) and Colorectal Cancer Treatments and Studies (10 papers). Xiaofeng Chen collaborates with scholars based in China, Norway and United States. Xiaofeng Chen's co-authors include Yongmei Yin, Yongqian Shu, Yiqian Liu, Yongqian Shu, Jinrong Qiu, Yanhong Gu, Oluf Dimitri Røe, Lingjun Zhu, Yingying Qian and Yang Shao and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Scientific Reports.

In The Last Decade

Xiaofeng Chen

82 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaofeng Chen China 19 520 424 388 319 195 87 1.2k
Jonghan Yu South Korea 23 560 1.1× 159 0.4× 352 0.9× 579 1.8× 222 1.1× 109 1.5k
Hark Kyun Kim South Korea 23 501 1.0× 542 1.3× 783 2.0× 344 1.1× 249 1.3× 62 1.6k
Shenglin Ma China 25 498 1.0× 459 1.1× 818 2.1× 518 1.6× 121 0.6× 92 1.7k
Tianzhu Qiu China 16 452 0.9× 180 0.4× 560 1.4× 452 1.4× 174 0.9× 29 1.2k
Weiting Ge China 20 393 0.8× 232 0.5× 564 1.5× 370 1.2× 121 0.6× 56 1.2k
Yuee Teng China 25 578 1.1× 273 0.6× 941 2.4× 491 1.5× 105 0.5× 86 1.6k
Sachin Kumar India 19 275 0.5× 247 0.6× 590 1.5× 520 1.6× 125 0.6× 64 1.3k
Daniel C. Rabe United States 14 366 0.7× 240 0.6× 637 1.6× 270 0.8× 111 0.6× 24 1.2k
Gabriele Zoppoli Italy 23 839 1.6× 215 0.5× 848 2.2× 550 1.7× 226 1.2× 96 1.9k
Derek J. Erstad United States 19 347 0.7× 196 0.5× 287 0.7× 270 0.8× 161 0.8× 50 1.2k

Countries citing papers authored by Xiaofeng Chen

Since Specialization
Citations

This map shows the geographic impact of Xiaofeng Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaofeng Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaofeng Chen more than expected).

Fields of papers citing papers by Xiaofeng Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaofeng Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaofeng Chen. The network helps show where Xiaofeng Chen may publish in the future.

Co-authorship network of co-authors of Xiaofeng Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaofeng Chen. A scholar is included among the top collaborators of Xiaofeng Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaofeng Chen. Xiaofeng Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Tongpeng, Xiaofeng Chen, Xiangrong Zuo, et al.. (2024). Efficacy and safety of novel multiple-chain DAP-CAR-T cells targeting mesothelin in ovarian cancer and mesothelioma: a single-arm, open-label and first-in-human study. Genome Medicine. 16(1). 133–133. 7 indexed citations
2.
3.
4.
5.
He, Hao, Yasmeen K. Tandon, Xiaofeng Chen, et al.. (2023). Right middle pulmonary vein classification by 3D-CT reconstruction and its clinical significance. Journal of Thoracic Disease. 15(12). 6868–6878.
6.
Xu, Tongpeng, Wenjie Wang, Junling Zhang, et al.. (2023). Anti-PD-1 plus anti-angiogenesis combined with chemotherapy in patients with HER2-negative advanced or metastatic gastric cancer: a multi-institutional retrospective study. Journal of Gastrointestinal Oncology. 14(1). 175–186. 3 indexed citations
7.
8.
Chen, Xiaofeng, et al.. (2021). Clinical application of three-dimensional transvaginal ultrasonography in the diagnosis of intrauterine adhesions. Journal of International Medical Research. 49(11). 3619085448–3619085448. 11 indexed citations
9.
Lü, Yi, Tao Qin, Xiaofeng Chen, et al.. (2021). Glutamine Metabolism Scoring Predicts Prognosis and Therapeutic Resistance in Hepatocellular Carcinoma. Pathology & Oncology Research. 27. 1610075–1610075. 14 indexed citations
10.
Zhao, Fengjiao, Yong Zhou, Yihong Zhang, et al.. (2020). Olaparib combined with immunotherapy for treating a patient with liver cancer carrying BRCA2 germline mutation. Medicine. 99(38). e22312–e22312. 6 indexed citations
11.
Ma, Ling, Zhangding Wang, Mengyan Xie, et al.. (2020). Silencing of circRACGAP1 sensitizes gastric cancer cells to apatinib via modulating autophagy by targeting miR-3657 and ATG7. Cell Death and Disease. 11(3). 169–169. 49 indexed citations
12.
Wang, Deqiang, Xiaoqin Li, Bo Shen, Xiaofeng Chen, & Yongqian Shu. (2019). Histone chaperone CHAF1A impacts the outcome of fluoropyrimidines-based adjuvant therapy in gastric cancer by regulating the expression of thymidylate synthetase. Gene. 716. 144034–144034. 8 indexed citations
13.
Qian, Yingying, Dong Pei, Ting Cheng, et al.. (2015). CD137 ligand-mediated reverse signaling inhibits proliferation and induces apoptosis in non-small cell lung cancer. Medical Oncology. 32(3). 44–44. 19 indexed citations
14.
Wu, Jialing, Chong Chen, Xi Hu, et al.. (2015). Suppressing Cyclooxygenase-2 Prevents nonalcoholic and inhibits apoptosis of hepatocytes that are involved in the Akt/p53 signal pathway. Biochemical and Biophysical Research Communications. 469(4). 1034–1040. 18 indexed citations
15.
Shen, Hua, Jianxin Shen, Min Wang, et al.. (2015). TGF-β1 induces erlotinib resistance in non-small cell lung cancer by down-regulating PTEN. Biomedicine & Pharmacotherapy. 77. 1–6. 20 indexed citations
16.
Qian, Yingying, Dong-Min Shi, Jinrong Qiu, et al.. (2015). ObRb downregulation increases breast cancer cell sensitivity to tamoxifen. Tumor Biology. 36(9). 6813–6821. 19 indexed citations
17.
Yang, Wenjie, Xiaofeng Wang, Xiaowei Li, et al.. (2014). The specific methylation characteristics of cancer related genes in Chinese colorectal cancer patients. Tumor Biology. 35(8). 8267–8279. 11 indexed citations
18.
Chen, Xiaofeng, Quan Zhu, Yiqian Liu, et al.. (2014). Icotinib Is an Active Treatment of Non-Small-Cell Lung Cancer: A Retrospective Study. PLoS ONE. 9(5). e95897–e95897. 25 indexed citations
19.
Chen, Xiaofeng, Yiqian Liu, Oluf Dimitri Røe, et al.. (2013). Gefitinib or Erlotinib as Maintenance Therapy in Patients with Advanced Stage Non-Small Cell Lung Cancer: A Systematic Review. PLoS ONE. 8(3). e59314–e59314. 50 indexed citations
20.
Chen, Xiaofeng, Wei Chen, Tingting Zhu, et al.. (2012). Leptin attenuates the anti-estrogen effect of tamoxifen in breast cancer. Biomedicine & Pharmacotherapy. 67(1). 22–30. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jonghan Yu Breakdown of academic impact, for papers by Hark Kyun Kim Breakdown of academic impact, for papers by Shenglin Ma Breakdown of academic impact, for papers by Tianzhu Qiu Breakdown of academic impact, for papers by Weiting Ge Breakdown of academic impact, for papers by Yuee Teng Breakdown of academic impact, for papers by Sachin Kumar Breakdown of academic impact, for papers by Daniel C. Rabe Breakdown of academic impact, for papers by Gabriele Zoppoli Breakdown of academic impact, for papers by Derek J. Erstad
Rankless by CCL
2026